Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 20, 2026 09:20 ET | Source: USA News Group

Western Capitals Rotate Into Sovereign Sanctuary: Antimony, Uranium, Graphite

VANCOUVER, British Columbia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary – China's antimony export whitelist, designating only 11 authorized firms through 2027[1], has...
January 15, 2026 09:00 ET | Source: Equity Insider

The $1.8T Energy Sprint: Why America is Betting Big on Strategic Mineral Platforms

VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary — The global clean energy infrastructure market is on a collision course with a $1.8 trillion valuation...
December 31, 2025 18:52 ET | Source: Pharma Corp Rx Inc.

PharmaCorp Announces Grant of Stock Options

PHARMACORP ANNOUNCES GRANT OF STOCK OPTIONS
December 31, 2025 17:28 ET | Source: Parkit Enterprise Inc.

Parkit Announces Grant of Options

Parkit Announces Grant of Options
December 24, 2025 17:24 ET | Source: ExGen Resources Inc

ExGen Signs Another Binding LOI to Acquire a Second Silver Stream on Past-Producing Gold Mine

EXGEN SIGNS ANOTHER BINDING LOI TO ACQUIRE A SECOND SILVER STREAM ON PAST-PRODUCING GOLD MINE
December 15, 2025 10:54 ET | Source: USA News Group

THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis

VANCOUVER, British Columbia, Dec. 15, 2025 (GLOBE NEWSWIRE) -- USANewsGroup.com Market Intelligence Brief – The market is repricing risk around a single variable: detection. The most dangerous...
November 28, 2025 09:15 ET | Source: NurExone Biologic Inc

NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company...
November 13, 2025 07:30 ET | Source: Pharma Corp Rx Inc.

PharmaCorp Announces Supplemental Listing of Warrants

PharmaCorp Announces Supplemental Listing of Warrants
October 24, 2025 07:55 ET | Source: SciSparc Ltd

SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio

TEL AVIV, Israel, Oct. 24, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
October 07, 2025 08:00 ET | Source: Cannara Biotech (Québec) Inc.

Cannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity Conversion

Cannara secures DTC eligibility to expand U.S. investor access and completes $6.2M debt-to-equity conversion, strengthening liquidity and balance sheet.